	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	199.34	204.30	249.92	234.55	257.13	290.96	284.55	323.19	299.79	255.62	361.77	364.88	367.19	358.60	362.01	368.46
Cost of Operating Revenue	124.35	123.99	150.89	140.71	147.36	210.13	207.10	237.42	206.19	168.71	226.27	242.43	248.91	237.13	234.28	226.18
Gross Profit	74.99	80.31	99.03	93.84	109.77	80.83	77.45	85.77	93.60	86.91	135.51	122.45	118.28	121.47	127.72	142.28
Gross Margin	37.6	39.3	39.6	40.0	42.7	27.8	27.2	26.5	31.2	34.0	37.5	33.6	32.2	33.9	35.3	38.6
Total Operating Expenses	186.20	190.22	231.83	235.25	250.12	276.26	272.30	304.39	275.79	239.96	321.17	339.60	346.16	341.00	336.09	342.44
Operating Profit	13.14	14.08	18.09	-0.70	7.01	14.69	12.25	18.80	24.00	15.67	40.60	25.28	21.03	17.60	25.92	26.02
Operating Margin	6.6	6.9	7.2	-0.3	2.7	5.0	4.3	5.8	8.0	6.1	11.2	6.9	5.7	4.9	7.2	7.1
Financing Income/(Expense) - Net	-9.80	-9.34	-10.76	-6.93	-7.97	-11.50	-11.85	-11.07	-13.66	-5.86	-13.34	-10.83	-15.80	-21.99	-23.79	-25.17
Profit before Taxes	2.93	7.70	9.46	9.05	1.71	4.79	0.81	8.04	10.77	10.36	27.35	16.71	5.63	3.66	4.84	5.19
Income Taxes	0.71	1.67	3.80	2.54	-0.82	-1.69	-1.78	3.95	1.44	3.43	9.22	4.29	2.42	-0.39	-0.42	-0.38
Profit after Tax	2.22	6.03	5.66	6.51	2.53	6.48	2.60	4.09	9.33	6.93	18.13	12.42	3.21	4.05	5.26	5.56
PAT Margin	1.1	3.0	2.3	2.8	1.0	2.2	0.9	1.3	3.1	2.7	5.0	3.4	0.9	1.1	1.5	1.5
EPS - Basic - ex Extraordinary Items	5.46	14.11	12.61	14.50	5.64	14.52	5.82	9.16	14.68	9.19	24.04	16.46	4.26	5.36	6.97	7.38
EPS - Diluted - ex Extraordinary Items	5.46	14.11	12.61	14.50	5.64	14.52	5.82	9.16	14.68	9.19	24.04	16.46	4.26	5.36	6.97	7.38
EBIT	13.14	14.08	18.09	-0.70	7.01	14.69	12.25	18.80	24.00	15.67	40.60	25.28	21.03	17.60	25.92	26.02
EBITDA	17.84	18.78	23.71	5.04	13.60	22.05	19.65	25.48	31.31	23.23	49.10	35.00	31.12	32.48	40.67	40.75
EBITDA Margin	9.0	9.2	9.5	2.1	5.3	7.6	6.9	7.9	10.4	9.1	13.6	9.6	8.5	9.1	11.2	11.1

Balance Sheet

Abridged

Understanding Balance Sheet

Reliance Chemotex Industries Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	54.64	58.77	63.22	78.18	81.84	72.29	79.73	74.78	75.63	106.07	130.88	146.13	156.33	153.13	182.48
Long-Term Investments	2.26	3.16	3.16	3.16	-	-	2.18	2.14	7.46	4.50	7.30	8.16	2.04	3.97	3.90
Property Plant & Equipment - Net	68.69	82.64	84.32	108.50	155.14	151.43	143.09	137.32	139.88	147.44	188.98	232.44	315.83	310.31	296.50
Total Non-Current Assets	73.42	88.03	90.90	113.22	158.48	154.93	148.04	143.30	151.82	156.58	202.32	250.83	324.69	321.23	329.48
Total Assets	128.05	146.79	154.12	191.39	240.32	227.22	227.77	218.07	227.45	262.65	333.21	396.96	481.03	474.36	511.96
Total Current Liabilities	57.18	51.25	51.84	59.98	83.66	82.40	92.68	79.57	80.35	102.53	136.70	165.44	163.85	167.95	170.25
Long Term Debt	32.38	46.14	43.13	63.48	73.88	60.13	51.70	50.32	29.53	34.73	49.41	68.67	151.76	140.34	146.76
Total Non-Current Liabilities	33.66	47.50	49.64	72.23	94.54	76.73	64.66	71.62	48.98	55.73	75.08	99.51	183.53	169.13	198.96
Total Liabilities	90.84	98.75	101.48	132.21	178.20	159.14	157.35	151.18	129.32	158.26	211.78	264.95	347.38	337.08	369.21
Total Shareholders' Equity	37.22	48.04	52.64	59.18	62.12	68.08	70.42	66.89	98.13	104.39	121.42	132.01	133.65	137.28	142.75
Total Equity	37.22	48.04	52.64	59.18	62.12	68.08	70.42	66.89	98.13	104.39	121.42	132.01	133.65	137.28	142.75
Total Liabilities & Equity	128.05	146.79	154.12	191.39	240.32	227.22	227.77	218.07	227.45	262.65	333.21	396.96	481.03	474.36	511.96

Cash Flow

Abridged

Understanding Cash Flow Statement

Reliance Chemotex Industries Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	2.54	17.02	16.11	-1.00	8.40	11.24	9.19	16.28	17.38	16.99	32.01	21.67	14.70	15.01	18.52
Working Capital - Increase/(Decrease)	4.16	-13.25	-0.62	-4.15	-1.84	10.91	-7.08	-0.01	-4.76	1.01	17.72	-32.33	-12.52	-25.86	-20.53
Net CF from Operating Activities	6.70	3.76	15.48	-5.14	6.57	22.15	2.11	16.27	12.62	18.01	49.73	-10.66	2.18	-10.84	-2.02
Capital Expenditures - Net	5.56	18.83	7.56	29.56	7.66	3.44	1.15	0.84	6.85	15.25	50.70	54.03	92.59	8.95	0.78
Net CF from Investing Activities	-5.56	-19.74	-7.31	-29.35	-8.01	-3.19	-1.08	-1.01	-8.16	-43.82	-76.03	-53.79	-85.41	30.54	-2.40
Dividends Paid - Cash - Total	0.79	1.67	3.40	0.61	2.51	2.31	2.79	2.79	1.51	0.70	1.51	1.89	1.89	0.75	0.38
Stock - Issuance/(Retirement) - Net	-	6.76	1.63	3.00	0.21	-	0.01	-	22.74	-	-	-	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	3.88	6.56	-6.74	21.28	5.71	-15.88	1.66	-12.10	-24.89	26.07	27.56	70.31	81.34	-18.64	4.62
Net Cash Flow from Financing Activities	-0.67	15.01	-10.01	35.85	1.79	-19.14	-1.59	-15.36	-3.82	25.36	26.05	68.42	79.45	-19.39	4.24
Free Cash Flow to Equity	5.02	-8.51	1.18	-13.42	4.62	2.83	2.63	3.33	-19.12	28.82	26.58	5.63	-9.06	-38.43	1.82
Free Operating CF net dividend	0.17	-19.26	4.47	-36.04	-3.81	16.22	-1.86	12.64	4.14	1.25	-3.82	-67.12	-92.30	-20.61	-3.17
Free Operating CF	0.96	-17.60	7.88	-35.43	-1.30	18.53	0.93	15.43	5.65	1.96	-2.31	-65.23	-90.42	-19.85	-2.80

Business Segment Analysis

FY End:

Mar 26

Reliance Chemotex Industries Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Yarns (100.0%)₹ 0.78 Cr

Revenue / Sales

Yarns (100.0%)₹ 362.01 Cr

Assets

Yarns (100.0%)₹ 511.96 Cr

Operating Income

Yarns (100.0%)₹ 25.92 Cr

Regional Segment Analysis

FY End:

Mar 26

Reliance Chemotex Industries Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

Domestic Market (65.5%)₹ 233.57 CrOverseas Market (34.5%)₹ 123.29 Cr

Historical Segment Analysis

Track how Reliance Chemotex Industries Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Yarns	7	16	52	55	93	9	1

Frequently Asked Questions

What is the revenue of Reliance Chemotex Industries Ltd.?

The latest trailing twelve month revenue of Reliance Chemotex Industries Ltd. is ₹ 368.46 Cr, reflecting a 1-year growth of 2.81% and a 3-year CAGR of 1.30%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Reliance Chemotex Industries Ltd.?

The latest trailing twelve month net profit (PAT) of Reliance Chemotex Industries Ltd. is ₹ 5.56 Cr, with a 3-year earnings CAGR of -21.38%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Reliance Chemotex Industries Ltd.?

The trailing twelve month EBITDA of Reliance Chemotex Industries Ltd. is approximately ₹ 26.02 Cr (based on an operating margin of 7.06%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Reliance Chemotex Industries Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Reliance Chemotex Industries Ltd. is 7.37. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Reliance Chemotex Industries Ltd.?

The debt-to-equity ratio of Reliance Chemotex Industries Ltd. stands at 1.87. The interest coverage ratio is 1.03x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Reliance Chemotex Industries Ltd.?

The estimated book value per share of Reliance Chemotex Industries Ltd. is 189.22 (derived from a P/B ratio of 0.57 and market price of ₹ 107.50), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Reliance Chemotex Industries Ltd.?

The trailing twelve month operating cash flow of Reliance Chemotex Industries Ltd. is ₹ -2.02 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Reliance Chemotex Industries Ltd. report consolidated or standalone financials?

Reliance Chemotex Industries Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.